Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,679 | 208 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,018 | 63 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $714.57 | 36 | $0 (2024) |
| PFIZER INC. | $364.38 | 18 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $210.65 | 10 | $0 (2024) |
| Allergan, Inc. | $139.51 | 10 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $125.43 | 7 | $0 (2023) |
| Merck Sharp & Dohme LLC | $123.22 | 8 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $120.37 | 9 | $0 (2023) |
| UCB, Inc. | $109.82 | 5 | $0 (2024) |
| ABBVIE INC. | $92.13 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $397.79 | 19 | Gilead Sciences, Inc. ($77.46) |
| 2023 | $527.08 | 24 | Janssen Pharmaceuticals, Inc ($159.92) |
| 2022 | $295.66 | 16 | Janssen Pharmaceuticals, Inc ($101.09) |
| 2021 | $294.60 | 18 | Janssen Pharmaceuticals, Inc ($143.09) |
| 2020 | $244.32 | 14 | Janssen Pharmaceuticals, Inc ($139.98) |
| 2019 | $702.68 | 42 | Janssen Pharmaceuticals, Inc ($213.28) |
| 2018 | $526.93 | 34 | Novartis Pharmaceuticals Corporation ($196.99) |
| 2017 | $690.34 | 41 | Novartis Pharmaceuticals Corporation ($268.45) |
All Payment Transactions
208 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.93 | General |
| 10/21/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Neurology | ||||||
| 10/09/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/04/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.84 | General |
| 08/26/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Neurology | ||||||
| 08/07/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.53 | General |
| 07/11/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/28/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Gastroenterology | ||||||
| 06/06/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Neurology | ||||||
| 05/21/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/16/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: VTE | ||||||
| 03/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Gastroenterology | ||||||
| 03/17/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.16 | General |
| 01/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Gastroenterology | ||||||
| 12/19/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/18/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/02/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $38.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/27/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.50 | General |
| 10/30/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/27/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.81 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 466 | 807 | $184,520 | $65,049 |
| 2022 | 6 | 539 | 927 | $185,008 | $69,436 |
| 2021 | 6 | 588 | 1,026 | $191,047 | $75,982 |
| 2020 | 8 | 714 | 1,278 | $226,405 | $93,537 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 133 | 274 | $72,151 | $25,861 | 35.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 156 | 335 | $60,165 | $21,088 | 35.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 113 | 113 | $26,801 | $10,202 | 38.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 49 | 49 | $22,298 | $6,473 | 29.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 15 | 36 | $3,105 | $1,425 | 45.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 149 | 318 | $68,602 | $25,246 | 36.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 176 | 391 | $58,235 | $22,068 | 37.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 135 | 138 | $29,774 | $11,464 | 38.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 55 | 56 | $23,194 | $8,682 | 37.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $3,408 | $1,293 | 37.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 12 | 12 | $1,795 | $683.38 | 38.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 217 | 512 | $72,192 | $29,157 | 40.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 131 | 270 | $54,810 | $22,253 | 40.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 137 | 140 | $29,540 | $11,651 | 39.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 67 | 67 | $26,599 | $10,198 | 38.3% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 12 | 12 | $4,356 | $1,398 | 32.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 24 | 25 | $3,550 | $1,325 | 37.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 255 | 647 | $91,227 | $37,928 | 41.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 165 | 327 | $66,381 | $27,777 | 41.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 187 | 196 | $41,356 | $16,951 | 41.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 38 | 38 | $15,086 | $6,086 | 40.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 19 | 19 | $5,130 | $1,967 | 38.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 19 | 19 | $2,698 | $1,073 | 39.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 15 | 15 | $2,130 | $914.15 | 42.9% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2020 | 16 | 17 | $2,397 | $840.82 | 35.1% |
About Dr. Prasad Rao, M.D
Dr. Prasad Rao, M.D is a Internal Medicine healthcare provider based in Cartersville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285656330.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Prasad Rao, M.D has received a total of $3,679 in payments from pharmaceutical and medical device companies, with $397.79 received in 2024. These payments were reported across 208 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,679).
As a Medicare-enrolled provider, Rao has provided services to 2,307 Medicare beneficiaries, totaling 4,038 services with total Medicare billing of $304,004. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist
- Location Cartersville, GA
- Active Since 07/24/2006
- Last Updated 10/08/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1285656330
Products in Payments
- XARELTO (Drug) $1,018
- ENTRESTO (Drug) $690.89
- ELIQUIS (Drug) $468.62
- XIFAXAN (Drug) $188.65
- JARDIANCE (Drug) $97.70
- Briviact (Drug) $87.95
- AVYCAZ (Drug) $83.16
- TEFLARO (Drug) $82.73
- SAMSCA (Drug) $71.84
- DALVANCE (Drug) $65.75
- DIFICID (Drug) $62.16
- SOLIRIS (Drug) $47.87
- ORBACTIV (Drug) $42.74
- Orbactiv (Drug) $38.59
- MINOCIN IV (Drug) $32.47
- FLOWTRIEVER CATHETER, S (Device) $31.15
- LifeVest (Device) $30.26
- FARXIGA (Drug) $29.80
- JANUVIA (Drug) $27.50
- LEQVIO (Drug) $23.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cartersville
Dr. David Kim, Md, MD
Internal Medicine — Payments: $12,616
Antonio Baute, Md, MD
Internal Medicine — Payments: $12,568
Christopher Inhulsen, Md, MD
Internal Medicine — Payments: $7,293
Sreedhar Maddineni, M.d, M.D
Internal Medicine — Payments: $4,706
Dr. Jeffrey Esslinger, M.d, M.D
Internal Medicine — Payments: $4,661
Dr. Willie Gilbert, Do, DO
Internal Medicine — Payments: $1,565